# Effect on HbA1c of the Initiation of CGM in Adults With Type 2 Diabetes Treated With Basal Insulin in Finland

> **NCT06268821** · NA · TERMINATED · sponsor: **Abbott Diabetes Care** · enrollment: 11 (actual)

## Conditions studied

- Type 2 Diabetes Treated With Insulin

## Interventions

- **DEVICE:** FreeStyle Libre 2 Flash Glucose Monitoring System

## Key facts

- **NCT ID:** NCT06268821
- **Lead sponsor:** Abbott Diabetes Care
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2024-04-02
- **Primary completion:** 2024-07-12
- **Final completion:** 2024-07-12
- **Target enrollment:** 11 (ACTUAL)
- **Why stopped:** Sponsor decision
- **Last updated:** 2024-09-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06268821

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06268821, "Effect on HbA1c of the Initiation of CGM in Adults With Type 2 Diabetes Treated With Basal Insulin in Finland". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06268821. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*